The Coffee Shop Origins of Factor V Leiden – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“Read our full profile on Frits Rosendaal, the 2026 ISTH Grant Medal recipient, and learn more about his life, including this anecdote:
How did they decide on the name Factor V Leiden for the mutation?
Rosendaal recalled the memory with a smile.’We were all gathered in the hospital coffee shop in the lobby. This was at a time when you were still allowed to drink beer and smoke in a hospital, so we were sitting there enjoying a drink and discussing how we should publicize it,’ he said.
Naming conventions for variant proteins often followed geography, typically the hometown of the first identified patient.
But in this case, there was no single ‘first patient,’ as the mutation had been identified through group studies.
So the team improvised with a bit of humor.
They joked that the first patient could have come from a nearby Dutch town but decided the international community might struggle with the pronunciation.
Instead, they chose a simpler, more recognizable name tied to their own institution:
Factor V Leiden, a name that ultimately stuck and became standard worldwide.

Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering